Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of antisense oligonucleotides for producing truncated Ig by exon skipping for the treatment of diseases involving B cells

Use of antisense oligonucleotides for producing truncated Ig by exon skipping for the treatment of diseases involving B cells

US Patent 10398722 · Granted Sep 3, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Transgenic non-human mammal for producing chimeric human immunoglobulin E antibo2018
Non-human transgenic mammal for the constant region of the class a human immunog2014